Search results
Your risk factor for heart attack: How University Hospitals' free calcium score test could save your...
WKYC Cleveland· 3 days agoFor several years now, University Hospitals has been offering free calcium score tests that can help...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 3 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 2 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
New Gel Makes Alcohol 50% Less Toxic, Curbs Organ Damage
Medscape· 1 day agoThe gel has only been tested in mice so far, but the researchers hope to make it available to people...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 5 days agoU.S. sales of Humira plummeted by 39.9% year over year in the first quarter to $1.8 billion....
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 1 day agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...
Healthcare's Hope in Artificial Intelligence
Medscape· 1 day agoAI is coming for healthcare, and that's a good thing.
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 5 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice President, U.S. Market...
Palisade's ulcerative colitis drug prevents symptoms in mice, is nontoxic in dogs
FierceBiotech· 2 days agoTwice-daily doses of Palisade's oral prodrug PALI-2108 for eight days protected mouse models of...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 12 hours agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...